CXCL8 and cancer: Activated c-met can activate the phosphatidylinositol 3-kinase and MAPK signaling pathway and upregulate expression of pro-angiogenesis factors interleukin-8 and vascular endothelial growth factor to induce angiogenesis and boost the development and metastasis of cancer [14].